Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Peter Libby MD
Peter Libby MD Advisory Board
Douglas Zipes MD
Douglas P. Zipes MD Editor-in-Chief
Ileana Piña MD, MPH, FAHA, FACC
Ileana L. Piña MD, MPH, FAHA, FACC Advisory Board
See All Experts
featured
Published in Cardiology

Journal Scan / Research · August 17, 2017

Impact of ACE Inhibitor and ARB Dose on Outcomes in Heart Failure

Circulation: Heart Failure

 

 Save  Recommend
 Share

Additional Info

Disclosure statements are available on the authors' profiles:

Clyde Yancy MD, MSc, MACC, FAHA, MACP, FHFSA

Circulation: Heart Failure
Dose of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers and Outcomes in Heart Failure: A Meta-Analysis
Circ Heart Fail 2017 Aug 01;10(8)e003956, MS Khan, GC Fonarow, A Ahmed, SJ Greene, M Vaduganathan, H Khan, C Marti, M Gheorghiade, J Butler

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading

Most Read This Week

Recently Updated